CORD-19:2008f024274c53b0de1276f4047a6a641813fd98 / 685842-686197 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/2008f024274c53b0de1276f4047a6a641813fd98","sourcedb":"CORD-19","sourceid":"2008f024274c53b0de1276f4047a6a641813fd98","text":"For Seasonal Allergic Rhinitis (SAR) patients that remain symptomatic on an H1-receptor antagonist, Cetirizine, and a nasal glucocorticosteroid, Mometasone furoate, the addition of Omalizumab, a recombinant, humanized, chimeric, anti-IgE monoclonal antibody, may provide additional efficacy in sub-optimally controlled Seasonal Allergic Rhinitis patients.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T65620","span":{"begin":0,"end":355},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T65620","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"Epistemic_Statements","denotations":[{"id":"T1136","span":{"begin":0,"end":355},"obj":"Epistemic_statement"}],"attributes":[{"subj":"T1136","pred":"source","obj":"Epistemic_Statements"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T83","span":{"begin":0,"end":355},"obj":"Sentence"}],"attributes":[{"subj":"T83","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T6306","span":{"begin":4,"end":30},"obj":"Disease"},{"id":"T6308","span":{"begin":319,"end":345},"obj":"Disease"}],"attributes":[{"id":"A6306","pred":"mondo_id","subj":"T6306","obj":"http://purl.obolibrary.org/obo/MONDO_0005324"},{"id":"A6307","pred":"mondo_id","subj":"T6306","obj":"http://purl.obolibrary.org/obo/MONDO_0011786"},{"id":"A6308","pred":"mondo_id","subj":"T6308","obj":"http://purl.obolibrary.org/obo/MONDO_0005324"},{"id":"A6309","pred":"mondo_id","subj":"T6308","obj":"http://purl.obolibrary.org/obo/MONDO_0011786"},{"subj":"T6306","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T6308","pred":"source","obj":"CORD-19-PD-MONDO"}]},{"project":"CORD-19-PD-HP","denotations":[{"id":"T3400","span":{"begin":13,"end":30},"obj":"Phenotype"},{"id":"T3401","span":{"begin":22,"end":30},"obj":"Phenotype"},{"id":"T3402","span":{"begin":328,"end":345},"obj":"Phenotype"},{"id":"T3403","span":{"begin":337,"end":345},"obj":"Phenotype"}],"attributes":[{"id":"A3400","pred":"hp_id","subj":"T3400","obj":"http://purl.obolibrary.org/obo/HP_0003193"},{"id":"A3401","pred":"hp_id","subj":"T3401","obj":"http://purl.obolibrary.org/obo/HP_0012384"},{"id":"A3402","pred":"hp_id","subj":"T3402","obj":"http://purl.obolibrary.org/obo/HP_0003193"},{"id":"A3403","pred":"hp_id","subj":"T3403","obj":"http://purl.obolibrary.org/obo/HP_0012384"},{"subj":"T3400","pred":"source","obj":"CORD-19-PD-HP"},{"subj":"T3401","pred":"source","obj":"CORD-19-PD-HP"},{"subj":"T3402","pred":"source","obj":"CORD-19-PD-HP"},{"subj":"T3403","pred":"source","obj":"CORD-19-PD-HP"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#ec93b4","default":true},{"id":"Epistemic_Statements","color":"#93ceec"},{"id":"CORD-19_Custom_license_subset","color":"#e8ec93"},{"id":"CORD-19-PD-MONDO","color":"#d593ec"},{"id":"CORD-19-PD-HP","color":"#93ecbb"}]}]}}